Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Telesis Bio Inc. | Director, 10%+ Owner | Redeemable Convertible Preferred Stock | 3.39M | $339M | $100.00 | Jun 5, 2023 | Indirect |
DICE Therapeutics, Inc. | 10%+ Owner | Common Stock | 634K | $29.5M | $46.50 | Jun 22, 2023 | By: Northpond Ventures, LP |
Vigil Neuroscience, Inc. | 10%+ Owner | Common Stock | 2.83M | $10.6M | $3.75 | Jan 11, 2022 | By: Northpond Ventures, LP |
DICE Therapeutics, Inc. | 10%+ Owner | Common Stock | 166K | $7.73M | $46.50 | Jun 22, 2023 | By: Northpond Ventures II, LP |
Vigil Neuroscience, Inc. | 10%+ Owner | Common Stock | 1.38M | $5.19M | $3.75 | Jan 11, 2022 | By: Northpond Ventures II, LP |
Telesis Bio Inc. | Director, 10%+ Owner | Long-Term Warrants | 3.39M | Jun 5, 2023 | Indirect | ||
Telesis Bio Inc. | Director, 10%+ Owner | Short-Term Warrants | 1.69M | Jun 5, 2023 | Indirect | ||
Vigil Neuroscience, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | Jan 11, 2022 | By: Northpond Ventures, LP | ||
Vigil Neuroscience, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jan 11, 2022 | By: Northpond Ventures II, LP |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DICE | DICE Therapeutics, Inc. | Jun 22, 2023 | 2 | -$116M | 4 | Jun 23, 2023 | 10%+ Owner |
TBIO | Telesis Bio Inc. | Jun 5, 2023 | 3 | $8M | 4 | Jun 7, 2023 | Director, 10%+ Owner |
VIGL | Vigil Neuroscience, Inc. | Jan 11, 2022 | 5 | $4.97M | 4 | Jan 11, 2022 | 10%+ Owner |
VIGL | Vigil Neuroscience, Inc. | Jan 6, 2022 | 0 | $0 | 3 | Jan 6, 2022 | 10%+ Owner |
DICE | DICE Therapeutics, Inc. | Sep 17, 2021 | 6 | $4M | 4 | Sep 20, 2021 | 10%+ Owner |
DICE | DICE Therapeutics, Inc. | Sep 14, 2021 | 0 | $0 | 3 | Sep 14, 2021 | 10%+ Owner |
TBIO | Codex DNA, Inc. | Jun 22, 2021 | 4 | $7.5M | 4 | Jun 24, 2021 | 10%+ Owner |
TBIO | Codex DNA, Inc. | Jun 17, 2021 | 0 | $0 | 3 | Jun 17, 2021 | 10%+ Owner |